Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$101.89 - $150.09 $1.43 Million - $2.11 Million
-14,046 Closed
0 $0
Q4 2021

Jun 21, 2023

BUY
$118.18 - $153.21 $1.66 Million - $2.15 Million
14,046 New
14,046 $2.11 Million
Q4 2021

Mar 30, 2023

SELL
$118.18 - $153.21 $6,381 - $8,273
-54 Reduced 0.38%
14,046 $2.11 Million
Q4 2021

Feb 15, 2022

SELL
$118.18 - $153.21 $6,381 - $8,273
-54 Reduced 0.38%
14,046 $2.11 Million
Q3 2021

Jun 21, 2023

BUY
$93.51 - $129.4 $1.33 Million - $1.83 Million
14,173 New
14,173 $1.69 Million
Q3 2021

Mar 30, 2023

BUY
$93.51 - $129.4 $940,056 - $1.3 Million
10,053 Added 248.41%
14,100 $1.68 Million
Q3 2021

Nov 15, 2021

BUY
$93.51 - $129.4 $940,056 - $1.3 Million
10,053 Added 248.41%
14,100 $1.68 Million
Q2 2021

Jun 21, 2023

BUY
$77.0 - $100.19 $311,619 - $405,468
4,047 New
4,047 $394,000
Q2 2021

Mar 30, 2023

BUY
$77.0 - $100.19 $9,856 - $12,824
128 Added 3.27%
4,047 $394,000
Q2 2021

Aug 16, 2021

BUY
$77.0 - $100.19 $311,311 - $405,068
4,043 Added 101075.0%
4,047 $394,000
Q1 2021

Jun 26, 2023

BUY
$81.28 - $104.34 $329,346 - $422,785
4,052 New
4,052 $358 Million
Q1 2021

Mar 30, 2023

SELL
$81.28 - $104.34 $24,709 - $31,719
-304 Reduced 7.2%
3,919 $345,000
Q1 2021

May 14, 2021

SELL
$81.28 - $104.34 $342,920 - $440,210
-4,219 Reduced 99.91%
4 $346,000
Q4 2020

Jun 22, 2023

BUY
$86.4 - $121.75 $364,867 - $514,150
4,223 New
4,223 $404,000
Q4 2020

Mar 30, 2023

BUY
$86.4 - $121.75 $345 - $487
4 Added 0.09%
4,223 $404,000
Q4 2020

Feb 16, 2021

BUY
$86.4 - $121.75 $345 - $487
4 Added 0.09%
4,223 $404,000
Q3 2020

Jun 26, 2023

BUY
$95.43 - $116.09 $402,619 - $489,783
4,219 New
4,219 $478,000
Q3 2020

Mar 30, 2023

SELL
$95.43 - $116.09 $4,771 - $5,804
-50 Reduced 1.17%
4,219 $478,000
Q3 2020

Nov 13, 2020

SELL
$95.43 - $116.09 $4,771 - $5,804
-50 Reduced 1.17%
4,219 $479,000
Q2 2020

Jun 26, 2023

BUY
$60.05 - $98.92 $256,353 - $422,289
4,269 New
4,269 $422,000
Q2 2020

Mar 30, 2023

SELL
$60.05 - $98.92 $762,094 - $1.26 Million
-12,691 Reduced 74.83%
4,269 $422,000
Q2 2020

Aug 14, 2020

SELL
$60.05 - $98.92 $762,094 - $1.26 Million
-12,691 Reduced 74.83%
4,269 $422,000
Q1 2020

Jul 12, 2023

BUY
$47.37 - $90.04 $803,395 - $1.53 Million
16,960 New
16,960 $1.09 Million
Q1 2020

Mar 30, 2023

SELL
$47.37 - $90.04 $35,053 - $66,629
-740 Reduced 4.18%
16,960 $1.09 Million
Q1 2020

May 15, 2020

SELL
$47.37 - $90.04 $35,053 - $66,629
-740 Reduced 4.18%
16,960 $1.09 Million
Q4 2019

Jul 12, 2023

BUY
$53.13 - $71.19 $940,401 - $1.26 Million
17,700 New
17,700 $1.06 Million
Q4 2019

Mar 30, 2023

SELL
$53.13 - $71.19 $14,185 - $19,007
-267 Reduced 1.49%
17,700 $1.06 Million
Q4 2019

Feb 14, 2020

SELL
$53.13 - $71.19 $14,185 - $19,007
-267 Reduced 1.49%
17,700 $1.06 Million
Q3 2019

Jul 12, 2023

BUY
$57.11 - $73.3 $1.03 Million - $1.32 Million
17,967 New
17,967 $1.06 Million
Q3 2019

Mar 30, 2023

BUY
$57.11 - $73.3 $86,350 - $110,829
1,512 Added 9.19%
17,967 $1.06 Million
Q3 2019

Nov 14, 2019

BUY
$57.11 - $73.3 $86,350 - $110,829
1,512 Added 9.19%
17,967 $1.06 Million
Q2 2019

Jul 12, 2023

BUY
$54.41 - $71.7 $912,074 - $1.2 Million
16,763 New
16,763 $1.08 Million
Q1 2019

Jul 13, 2023

BUY
$32.25 - $73.56 $530,673 - $1.21 Million
16,455 New
16,455 $1.04 Million
Q1 2019

Mar 30, 2023

BUY
$32.25 - $73.56 $530,673 - $1.21 Million
16,455 New
16,455 $1.04 Million
Q1 2019

May 16, 2019

SELL
$32.25 - $73.56 $78,464 - $178,971
-2,433 Reduced 12.88%
16,455 $1.04 Million
Q1 2019

May 15, 2019

BUY
$32.25 - $73.56 $64,467 - $147,046
1,999 Added 11.84%
18,888 $223,000
Q4 2018

Jul 13, 2023

BUY
$28.45 - $40.65 $480,492 - $686,537
16,889 New
16,889 $641,000
Q4 2018

Feb 14, 2019

BUY
$28.45 - $40.65 $378,015 - $540,116
13,287 Added 368.88%
16,889 $641,000
Q3 2018

Jul 13, 2023

BUY
$21.39 - $51.17 $351,801 - $841,592
16,447 New
16,447 $705 Million
Q3 2018

Nov 14, 2018

BUY
$21.39 - $51.17 $77,046 - $184,314
3,602 New
3,602 $154,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.38B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.